31st Mar 2021 13:01
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 30 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,726,628 | 1.34% | 190,301 | 0.15% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
102,935 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,835,663 | 1.42% | 203,467 | 0.16% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 67 | 233.9700 USD |
| Purchase | 100 | 234.3350 USD |
| Purchase | 345 | 232.4429 USD |
| Purchase | 937 | 232.6760 USD |
| Purchase | 998 | 233.6505 USD |
| Purchase | 2,000 | 232.6095 USD |
| Purchase | 2,330 | 233.6075 USD |
| Purchase | 2,419 | 233.2298 USD |
| Purchase | 2,809 | 232.3100 USD |
| Purchase | 2,907 | 232.3897 USD |
| Purchase | 4,376 | 234.3926 USD |
| Purchase | 5,648 | 232.6832 USD |
| Purchase | 6,700 | 233.9962 USD |
| Sale | 18 | 233.7100 USD |
| Sale | 50 | 234.4000 USD |
| Sale | 94 | 232.7137 USD |
| Sale | 100 | 233.7200 USD |
| Sale | 100 | 233.5700 USD |
| Sale | 100 | 233.9700 USD |
| Sale | 200 | 234.0400 USD |
| Sale | 200 | 232.7650 USD |
| Sale | 285 | 232.1700 USD |
| Sale | 292 | 233.9035 USD |
| Sale | 300 | 234.1416 USD |
| Sale | 324 | 234.1191 USD |
| Sale | 400 | 234.8900 USD |
| Sale | 470 | 234.0653 USD |
| Sale | 495 | 234.6939 USD |
| Sale | 608 | 234.0500 USD |
| Sale | 780 | 233.6505 USD |
| Sale | 930 | 233.1083 USD |
| Sale | 1,098 | 234.0222 USD |
| Sale | 1,300 | 233.9675 USD |
| Sale | 1,480 | 233.0115 USD |
| Sale | 1,642 | 233.3506 USD |
| Sale | 2,011 | 232.3100 USD |
| Sale | 2,387 | 234.3700 USD |
| Sale | 2,813 | 232.3789 USD |
| Sale | 3,044 | 233.1242 USD |
| Sale | 4,580 | 232.5778 USD |
| Sale | 4,737 | 233.6946 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 31 Mar 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price |
| date | |
| to which the option |
|
|
| |
| or derivative |
|
|
| |
| relates |
|
|
| |
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210331005559/en/
Copyright Business Wire 2021
Related Shares:
Barclays